• Login
    View Item 
    •   NRU
    • Journal Publications
    • Medical and Health Sciences
    • Medical and Health Sciences
    • View Item
    •   NRU
    • Journal Publications
    • Medical and Health Sciences
    • Medical and Health Sciences
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    A Prospective Evaluation of Xpert MTB/RIF Ultra for Childhood Pulmonary Tuberculosis in Uganda

    Thumbnail
    View/Open
    Article (520.5Kb)
    Date
    2021
    Author
    Jaganath, Devan
    Wambi, Peter
    Reza, Tania F.
    Nakafeero, Jascent
    Aben, Ernest O.
    Kiconco, Emma
    Nannyonga, Gertrude
    Nsereko, Moses
    Sekadde, Moorine P.
    Mudiope, Mary
    Kato-Maeda, Midori
    Starke, Jeffrey
    Andama, Alfred
    Mohanty, Swomitra
    Wobudeya, Eric
    Cattamanchi, Adithya
    Metadata
    Show full item record
    Abstract
    Xpert MTB/RIF Ultra (Xpert Ultra) has improved the sensitivity to detect pulmonary tuberculosis (TB) in adults. However, there have been limited prospective evaluations of its diagnostic accuracy in children. Methods. We enrolled children undergoing assessment for pulmonary TB in Kampala, Uganda, over a 12-month period. Children received a complete TB evaluation and were classified as Confirmed, Unconfirmed, or Unlikely TB. We calculated the sensitivity and specificity of Xpert Ultra among children with Confirmed vs Unlikely TB. We also determined the diagnostic accuracy with clinical, microbiological, and extended microbiological reference standards (MRSs). Results. Of the 213 children included, 23 (10.8%) had Confirmed TB, 88 (41.3%) had Unconfirmed TB, and 102 (47.9%) had Unlikely TB. The median age was 3.9 years, 13% were HIV-positive, and 61.5% were underweight. Xpert Ultra sensitivity was 69.6% (95% confidence interval [CI]: 47.1-86.8) among children with Confirmed TB and decreased to 23.4% (95% CI: 15.9-32.4) with the clinical reference standard. Specificity was 100% (95% CI: 96.4-100) among children with Unlikely TB and decreased to 94.7% (95% CI: 90.5-97.4) with a MRS. Sensitivity was 52.9% (95% CI: 35.1-70.2) and specificity 95.5% (95% CI: 91.4-98.1) with the extended MRS. Of the 26 positive Xpert Ultra results, 6 (23.1%) were “Trace-positive,” with most (5/6) occurring in children with Unconfirmed TB. Conclusions. Xpert Ultra is a useful tool for diagnosing pulmonary TB in children, but there remains a need for more sensitive tests to detect culture-negative TB.
    URI
    https://nru.uncst.go.ug/handle/123456789/2939
    Collections
    • Medical and Health Sciences [3670]

    Research Dissemination Platform copyright © since 2021  UNCST
    Contact Us | Send Feedback
    Partners
     

     

    Browse

    All of NRU
    Communities & CollectionsBy Issue DateAuthorsTitlesSubjects
    This Collection
    By Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    View Usage Statistics

    Research Dissemination Platform copyright © since 2021  UNCST
    Contact Us | Send Feedback
    Partners